FDA NDC Directory · JSON-LD · Markdown

Zeptide Insulin Cartridge Blend

NDC 87994-011 · DRUG FOR FURTHER PROCESSING · SUSPENSION

Labeler / ManufacturerTirzepatide Pharma
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeSUSPENSION
Active ingredientsINSULIN ASPART (30 U/1)
ISOPHANE INSULIN HUMAN SUSPENSION (70 U/1)
Marketing started20260901
Package count1

External sources

Source: openFDA. Public-domain (CC0).